About James La Rossa

This author has not yet filled in any details.
So far James La Rossa has created 176 blog entries.

Noted Researcher, Charles B. Nemeroff, Outlines Future of Psychiatric Development at APA Meeting

By |2016-05-15T16:24:36-07:00May 15th, 2016|We Know Psychiatry|

Sunday, May 15, 2016. APA Meeting, Atlanta GA. Charles B. Nemeroff, MD, PhD, the Leonard M. Miller Professor & Chairman, Department of Psychiatry and Behavioral Sciences and Director, Center on Aging at the University of Miami Health System, addressed areas of future research at the APA convocation today. "Micro RNA is [...]

New Research: Veterans with PTSD See Reduction in Symptoms; ECT for Schizophrenics and Eating Disorders by Gender, also Reported

By |2016-05-14T21:00:06-07:00May 14th, 2016|We Know Psychiatry|

Saturday, May 14, 2016. APA Meeting, Atlanta GA. The American Psychiatric Association (APA) convocation, which began today, highlighted initial findings in a number of key and unique mental diseases. Adopting a Dog May Help Veterans with PTSD Adopting a pet dog may prove a useful addition to treatment for veterans [...]

Citing Stigma of Mental Illness, Weil Family Donates $185 Million for Neuroscience Center at U.C.S.F

By |2016-04-26T14:41:09-07:00April 26th, 2016|We Know Psychiatry|

The philanthropists, Sanford I. Weill and his wife, Joan, have made the largest donation in the University of California, San Francisco's  (UCSF) history, to finance a neuroscience center to provide "research on the brain, which is the most complex part of the human body," and is far behind other areas [...]

Psychopharmacology Bulletin, Vol. 46, No. 1, 2016, On-Line Now

By |2016-04-13T15:52:36-07:00April 13th, 2016|We Know Psychiatry|

    For Immediate Release April 13, 2016. Los Angeles CA www.medworksmedia.com Psychopharmacology Bulletin Volume 46, Number 1, 2016, On-Line Now Replica Journal Issue Available for Readers ORIGINAL RESEARCH A Randomized, Placebo-Controlled Pilot Study of Quetiapine-XR Monotherapy or Adjunctive Therapy to Antidepressant in Acute Major Depressive Disorder with Current Generalized [...]

NUTRITIONAL DRINK MAY HELP REDUCE BRAIN SHRINKAGE AND SLOW SYMPTOMS OF ALZHEIMER’S DISEASE, EU STUDY SHOWS

By |2016-03-15T16:20:17-07:00March 15th, 2016|We Know Psychiatry|

In a recent study, researchers looked at the possibility of using nutritional intervention to slow the onset of certain Alzheimer’s symptoms. The study involved a particular nutritional drink called Souvenaid http://www.souvenaid-us.com/, which was given to patients in the pre-dementia (prodromal) stage of Alzheimer’s once a day for a twelve month [...]

Psychopharmacology Bulletin Pens Ventures with EbscoHost, Elsevier, and Bio-Press; 2016 Issues, Set for Index Medicus, are In Press

By |2016-03-05T22:18:10-08:00March 5th, 2016|We Know Psychiatry|

For Immediate Release March 7, 2016. Los Angeles CA Contact: James La Rossa Jr., 310.374.1300 2016 Issues, Set for Index Medicus, are In Press Psychopharmacology Bulletin — reactivated by the National Library of Medicine — has finalized a series of agreements with the largest repositories of acquisitions medical libraries. Bulletin [...]

Medical Advertising in the Crosshairs

By |2016-02-29T16:31:12-08:00February 29th, 2016|We Know Psychiatry|

In the summer of 1997, I was months away from launching the first consumer magazine about mental illness. My company had acquired a state and federal trademark for the title, Mental Fitness (The Science of Mental Wellness). I had done a long interview with the veteran 60 Minutes journalist, Mike [...]

Go to Top